Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion
- PMID: 15919096
- DOI: 10.1016/j.lfs.2005.04.009
Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion
Abstract
Echinacea is a widely used herbal remedy for the treatment of colds and other infections. However, almost nothing is known about the disposition and pharmacokinetics of any of its components, particularly the alkamides and caffeic acid conjugates which are thought to be the active phytochemicals. In this investigation, we have examined serial plasma samples from 9 healthy volunteers who ingested echinacea tablets manufactured from ethanolic liquid extracts of Echinacea angustifolia and Echinacea purpurea immediately after a standard high fat breakfast. Caffeic acid conjugates could not be identified in any plasma sample at any time after tablet ingestion. Alkamides were rapidly absorbed and were measurable in plasma 20 min after tablet ingestion and remained detectable for up to 12 h. Concentration-time curves for 2,4-diene and 2-ene alkamides were determined. The maximal concentrations for the sum of alkamides in human plasma were reached within 2.3 h post ingestion and averaged 336+/-131 ng eq/mL plasma. No obvious differences were observed in the pharmacokinetics of individual or total alkamides in 2 additional fasted subjects who took the same dose of the echinacea preparation. This single dose study provides evidence that alkamides are orally available and that their pharmacokinetics are in agreement with the one dose three times daily regimen already recommended for echinacea.
Similar articles
-
Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations.Phytomedicine. 2007 Sep;14(9):587-90. doi: 10.1016/j.phymed.2006.12.021. Epub 2007 Feb 7. Phytomedicine. 2007. PMID: 17289362
-
Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins.J Agric Food Chem. 2005 Nov 30;53(24):9413-23. doi: 10.1021/jf0502395. J Agric Food Chem. 2005. PMID: 16302756
-
Bioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugates.Molecules. 2005 Oct 30;10(10):1242-51. doi: 10.3390/10101242. Molecules. 2005. PMID: 18007516 Free PMC article. Clinical Trial.
-
The role of alkamides as an active principle of echinacea.Planta Med. 2007 Jun;73(7):615-23. doi: 10.1055/s-2007-981531. Epub 2007 May 31. Planta Med. 2007. PMID: 17538868 Review.
-
Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.J Pharm Pharmacol. 2005 Aug;57(8):929-54. doi: 10.1211/0022357056127. J Pharm Pharmacol. 2005. PMID: 16102249 Review.
Cited by
-
Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects.Br J Clin Pharmacol. 2010 May;69(5):508-15. doi: 10.1111/j.1365-2125.2010.03620.x. Br J Clin Pharmacol. 2010. PMID: 20573086 Free PMC article. Clinical Trial.
-
Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida.Br J Pharmacol. 2008 Mar;153(5):879-85. doi: 10.1038/sj.bjp.0707639. Epub 2008 Jan 14. Br J Pharmacol. 2008. PMID: 18193076 Free PMC article.
-
Anxiofit-1 and reduction of subthreshold and mild anxiety: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.EFSA J. 2020 Oct 22;18(10):e06264. doi: 10.2903/j.efsa.2020.6264. eCollection 2020 Oct. EFSA J. 2020. PMID: 33117457 Free PMC article.
-
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.Mol Nutr Food Res. 2008 Jul;52(7):772-9. doi: 10.1002/mnfr.200700081. Mol Nutr Food Res. 2008. PMID: 18214850 Free PMC article.
-
Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers.Evid Based Complement Alternat Med. 2012;2012:417267. doi: 10.1155/2012/417267. Epub 2011 Dec 20. Evid Based Complement Alternat Med. 2012. PMID: 22229040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
